Amgen has announced a $650 million expansion of its U.S. manufacturing network to support increased drug production at the company’s biologics manufacturing facility in Juncos, Puerto Rico, and to integrate innovative advanced technologies throughout the operations process. The expansion is expected to create nearly 750 jobs, including construction roles and new highly skilled manufacturing jobs. “This expansion underscores Amgen’s commitment to U.S. biomanufacturing and ...